EP3C: Evaluation of Therapeutic Strategies in Pediatric Cataract Surgery

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02253017
Collaborator
(none)
0
1
15
0

Study Details

Study Description

Brief Summary

The purpose of this observational study is to assess the therapeutic strategies in the treatment of pediatric cataracts.

Condition or Disease Intervention/Treatment Phase
  • Other: Children operated on for cataract

Detailed Description

Technical progress and recently described potential issues have recently challenged the surgical treatment of pediatric cataracts. Many questions remain unsolved: primary vs secondary implantation, nature of the implant used. The aim of this study is to establish a systematic prospective register of all cataracts operated on in a tertiary pediatric centre in order to help answering these questions.

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Assessment Practices Registry in Congenital Cataract Surgery and Infantile
Anticipated Study Start Date :
Sep 1, 2014
Anticipated Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Children operated on for cataract

Other: Children operated on for cataract
Compilation of results of monitoring of children aged 8 to 10 months, 3 years, 5 years, 8 years

Outcome Measures

Primary Outcome Measures

  1. Assessment practices in Pediatric Cataract Surgery. [8-10 months,]

    Rating of efficacy of surgery depending on the implementation or not of a primary location Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal) Evaluation of effectiveness of surgery based on age (<8 weeks of age for unilateral surgery and <11 weeks of life for bilateral surgeries) To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary

  2. Assessment practices in Pediatric Cataract Surgery. [3 years]

    Rating of efficacy of surgery depending on the implementation or not of a primary location Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal) Evaluation of effectiveness of surgery based on age (<8 weeks of age for unilateral surgery and <11 weeks of life for bilateral surgeries) To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary

  3. Assessment practices in Pediatric Cataract Surgery. [5 years]

    Rating of efficacy of surgery depending on the implementation or not of a primary location Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal) Evaluation of effectiveness of surgery based on age (<8 weeks of age for unilateral surgery and <11 weeks of life for bilateral surgeries) To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary

  4. Assessment practices in Pediatric Cataract Surgery. [8 years (or 6 months after surgery if the child is carried out after 8 years )]

    Rating of efficacy of surgery depending on the implementation or not of a primary location Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal) Evaluation of effectiveness of surgery based on age (<8 weeks of age for unilateral surgery and <11 weeks of life for bilateral surgeries) To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary

Secondary Outcome Measures

  1. Type of surgery and surgical procedures [8-10 months]

  2. Type of surgery and surgical procedures [3 years]

  3. Type of surgery and surgical procedures [5 years]

  4. Type of surgery and surgical procedures [8 years (or 6 months after surgery if the child is carried out after 8 years).]

    8 years (or 6 months after surgery if the child is carried out after 8 years).

  5. Type of implant [8-10 months]

  6. Type of implant [3 years]

  7. Type of implant [5 years]

  8. Type of implant [8 years (or 6 months after surgery if the child is carried out after 8 years).]

  9. Age at implantation [8-10 months,]

  10. Age at implantation [3 years,]

  11. Age at implantation [5 years]

  12. Age at implantation [8 years (or 6 months after surgery if the child is carried out after 8 years).]

  13. Distance visual acuity [age of 8 years and 6 months after surgery if the child is carried out after the age of 8.]

Eligibility Criteria

Criteria

Ages Eligible for Study:
0 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Child cataract surgery from 1 September 2014 in the Department of Ophthalmology, University Hospital Necker-Enfants Malades

  • Children aged between 0 and 17 years

  • Child with unilateral or bilateral cataract

Exclusion Criteria:
  • Child with bilateral cataract, one eye having previously been operated in another center.

  • Children whose parents have notified the doctor their refusal of data collection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Necker - Enfants Malades (Assistance Publique-Hôpitaux de Paris) Paris France 75015

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris

Investigators

  • Principal Investigator: Matthieu Robert, MD, Hôpital Necker - Enfants Malades, Assistance Publique-Hôpitaux de Paris, France

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT02253017
Other Study ID Numbers:
  • 2014-06-13
First Posted:
Oct 1, 2014
Last Update Posted:
May 4, 2021
Last Verified:
Apr 1, 2021
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 4, 2021